The supply of Pralidoxime Chloride 2026

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

This public procurement record has 1 release in its history.

Planning

14 Aug 2026 at 14:58

Summary of the contracting process

The UK Health Security Agency, acting for the Secretary of State for Health and Social Care, is planning to buy Pralidoxime Chloride, a pharmaceutical product used in the UK. The requirement concerns supply of the medicine rather than associated works or services. Delivery is across the United Kingdom. The procurement is classified as goods and is presented as a single requirement. This is a central-government procurement led by UKHSA’s preparedness and countermeasures function. Suppliers active in pharmaceutical manufacture, wholesaling, distribution or medicines supply chains should assess whether they can provide Pralidoxime Chloride for UK delivery and meet the information and confidentiality conditions that will apply before the later procurement stages.

This process is at the planning and preliminary market-engagement stage, before an invitation to tender. UKHSA expects to issue a subsequent notice on 4 September 2026. The planned contract period is 27 November 2026 to 27 November 2028. The published procurement value is £1 gross, in GBP, and the requirement is marked above the relevant threshold. It is one planned lot, assessed as suitable for SMEs. Suppliers interested in being considered must confirm participation by close of business on 28 August 2026. Participation requires contacting UKHSA to access a non-disclosure agreement; the NDA must be completed before tender documentation can be accessed. Only participating suppliers will be considered for the tender process and later award.

This planning exercise is most relevant to suppliers with an established ability to source, manufacture, hold and distribute Pralidoxime Chloride as a pharmaceutical product throughout the United Kingdom. It may suit both larger medicines businesses and smaller specialist pharmaceutical suppliers, since the planned lot is identified as suitable for SMEs. Interested organisations should prepare to demonstrate that they can support a national supply requirement and engage under the buyer’s confidentiality arrangements. The NDA is a practical prerequisite for accessing the tender documentation, so businesses should be ready to provide the requested organisational details and confirm participation. Suppliers outside pharmaceutical supply and distribution, or unable to support UK-wide delivery, are unlikely to be well placed.

How relevant is this notice?

Notice Title

The supply of Pralidoxime Chloride 2026

Notice Description

UKHSA is inviting suppliers to participate in a preliminary market engagement exercise for Pralidoxime Chloride through this Request for Information (RFI), in accordance with the Procurement Act 2023. Suppliers wishing to be considered for inclusion in this procurement exercise must confirm their participation by the stated deadline. Suppliers who do not participate will not be included in the procurement process or considered for subsequent stages.

Planning Information

Important: Only suppliers who participate in this procurement exercise will be considered for inclusion in the tender process. Suppliers who do not participate will not be invited to proceed further or be considered for award. If your organisation is interested in this requirement, please contact commercial.preparednessandcountermeasures@ukhsa.gov.uk by COP 28th of August 2026 to access the NDA. Please note a Non-Disclosure Agreement (NDA) is required prior to gaining access to the tender documentation.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e4cd
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/077753-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
14 Aug 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
4 Sep 20262 weeks to go
Award Date
Not specified
Contract Period
27 Nov 2026 - 27 Nov 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified

Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...